About KiOmed Pharma
KiOmed Pharma is a company based in Herstal (Belgium) founded in 2012.. KiOmed Pharma has raised $6.73 million across 1 funding round. The company has 20 employees as of December 31, 2022. KiOmed Pharma offers products and services including Aptissen, KiOmedine Dermal Fillers, and KiOmedine Eyedrops. KiOmed Pharma operates in a competitive market with competitors including ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others.
- Headquarter Herstal, Belgium
- Employees 20 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kiomed Pharma
-
Annual Revenue
$11.56 M (USD)71as on Dec 31, 2022
-
Net Profit
$3.13 M (USD)251as on Dec 31, 2022
-
EBITDA
$5.87 M (USD)72as on Dec 31, 2022
-
Total Equity Funding
$6.73 M (USD)
in 1 rounds
-
Latest Funding Round
$6.73 M (USD), Series A
Jun 16, 2016
-
Investors
-
Employee Count
20
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KiOmed Pharma
KiOmed Pharma offers a comprehensive portfolio of products and services, including Aptissen, KiOmedine Dermal Fillers, and KiOmedine Eyedrops. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implant for treating osteoarthritis symptoms and joint discomfort.
Fillers for skin protection, hydration, and collagen stimulation.
Formulations for hydrating and protecting eye tissues against disorders.
Funding Insights of KiOmed Pharma
KiOmed Pharma has successfully raised a total of $6.73M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.73 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.7M
-
First Round
First Round
(16 Jun 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Series A - KiOmed Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by KiOmed Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KiOmed Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kiomed Pharma Comparisons
Competitors of KiOmed Pharma
KiOmed Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about KiOmed Pharma
When was KiOmed Pharma founded?
KiOmed Pharma was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Where is KiOmed Pharma located?
KiOmed Pharma is headquartered in Herstal, Belgium. It is registered at Herstal, Liege, Belgium.
Is KiOmed Pharma a funded company?
KiOmed Pharma is a funded company, having raised a total of $6.73M across 1 funding round to date. The company's 1st funding round was a Series A of $6.73M, raised on Jun 16, 2016.
How many employees does KiOmed Pharma have?
As of Dec 31, 2022, the latest employee count at KiOmed Pharma is 20.
What is the annual revenue of KiOmed Pharma?
Annual revenue of KiOmed Pharma is $11.56M as on Dec 31, 2022.
What does KiOmed Pharma do?
KiOmed Pharma was founded in 2012 in Herstal, Belgium, within the biotechnology sector. Patented technologies based on animal-free ultrapure chitosan biopolymer are integrated into products for surgical hemostats, regenerative medicine, ophthalmology, and joint health. Operations focus on development and application of these biopolymers across various medical fields, with a domain at kiomedpharma.com.
Who are the top competitors of KiOmed Pharma?
KiOmed Pharma's top competitors include Sino Biological, OncoDNA and ArcherDX.
What products or services does KiOmed Pharma offer?
KiOmed Pharma offers Aptissen, KiOmedine Dermal Fillers, and KiOmedine Eyedrops.